Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Modeling of Breast Cancer Prognostic Factors Using a Parametric Log-Logistic Model in Fars Province, Southern Iran

  • Zare, Najaf (Department of Biostatistics, Shiraz University of Medical Sciences) ;
  • Doostfatemeh, Marzieh (Department of Biostatistics, Shiraz University of Medical Sciences) ;
  • Rezaianzadeh, Abass (Research Center for Health Sciences, Department of Epidemiology, Shiraz University of Medical Sciences)
  • Published : 2012.04.30
Download PDF
⟨ Previous Next ⟩

Abstract

In general, breast cancer is the most common malignancy among women in developed as well as some developing countries, often being the second leading cause of cancer mortality after lung cancer. Using a parametric log-logistic model to consider the effects of prognostic factors, the present study focused on the 5-year survival of women with the diagnosis of breast cancer in Southern Iran. A total of 1,148 women who were diagnosed with primary invasive breast cancer from January 2001 to January 2005 were included and divided into three prognosis groups: poor, medium, and good. The survival times as well as the hazard rates of the three different groups were compared. The log-logistic model was employed as the best parametric model which could explain survival times. The hazard rates of the poor and the medium prognosis groups were respectively 13 and 3 times greater than in the good prognosis group. Also, the difference between the overall survival rates of the poor and the medium prognosis groups was highly significant in comparison to the good prognosis group. Use of the parametric log-logistic model - also a proportional odds model - allowed assessment of the natural process of the disease based on hazard and identification of trends.

Keywords

References

  1. Abadi A , Saadat S, Yavari P, Bajdik C, Jalili P (2011). Comparison of Aalen's additive and Cox proportional hazards models for breast cancer survival: analysis of population-based data from British Columbia, Canada. Asian Pac J Cancer Prev, 12, 3113-16
  2. Al-Moundhri M, Al-Bahrani B, Pervez I, et al (2004). The outcome of treatment of breast cancer in a developing country - Oman. The Breast, 13, 139-45. https://doi.org/10.1016/j.breast.2003.10.001
  3. Ardoino I, Ambrogi F, Bajdik C , et al (2012). Flexible parametric modelling of the hazard function in breast cancer studies. Applied Statistics, Taylor & France.
  4. Blamey RW, Ellis IO, Pinder SE, et al (2007). Survival of invasive breast cancer according to the Nottingham Prognostic Index in cases diagnosed in 1990-1999. Eur J Cancer, 43, 1548-55. https://doi.org/10.1016/j.ejca.2007.01.016
  5. Collett D(2003). Modelling Survival Data in Medical Research. Chapman and Hall.
  6. D'Eredita G, Martellotta M, Natale T, Ferrarese F(2001). Prognostic factors in breast cancer: the predictive value of the Nottingham Prognostic Index in patients with a long term follow-up and treated in a single institution. Eur J Cancer, 37, 591-6. https://doi.org/10.1016/S0959-8049(00)00435-4
  7. Fisch T, Pury P, Probst N, et al (2005). Variation in survival after diagnosis of breast cancer in Switzerland. Ann Oncol, 16, 1882-8. https://doi.org/10.1093/annonc/mdi404
  8. Foo CS, Su D, Chong CK, et al (2005), Breast cancer in young Asian women: Study on survival. ANZ J Surg, 75, 566-72. https://doi.org/10.1111/j.1445-2197.2005.03431.x
  9. Galea MH, Blamey RW, Elston CE, Ellis IO (1992). The Nottingham Prognostic Index in primary breast cancer. Br Cancer Res Treat, 2, 207-21.
  10. Grau AM, Ata A, Foster L, et al (2005). Effect of race on longterm survival of breast cancer patients: Transinstitutional analysis from an inner city hospital and university medical center. Am Surg, 71, 164-70.
  11. Kalbfleish JD, Prentice RL(2002). The Statistical Analysis of Failure Time Data. Wiley-Interscience.
  12. Kim KJ, Huh SJ, Yang JH, et al (2005). Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy. Jpn J Clin Oncol, 35, 126-33. https://doi.org/10.1093/jjco/hyi039
  13. Lambert PC, Royston P (2009).Further development of flexible parametric models for survival analysis.The Stata J, 9, 265-90
  14. Nagel G, Wedding U, Hoyer H, Röhrig B, Katenkamp D(2004). The impact of comorbidity on the survival of postmenopausal women with breast cancer. J Cancer Res & Clin Oncol, 130, 664-70. https://doi.org/10.1007/s00432-004-0594-3
  15. Rezaianzadeh A , Peacock J, Reidpath D, et al (2009). Survival analysis of 1148 women diagnosed with breast cancer in Southern Iran. BMC Cancer, 9, 168-78 https://doi.org/10.1186/1471-2407-9-168
  16. Royston P (2001). Flexible parametric alternatives to the Cox model, and more. Stata J, 1, 1-28.
  17. Royston P, Parmar MK(2002). Flexible parametric proportionalhazards and proportional-odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects. Statistics in Med, 21, 2175-97. https://doi.org/10.1002/sim.1203
  18. Royston P, Sauerbrei W (2003). Building multivariable prognostic and diagnostic models: transformation of the predictors by using fractional polynomials source. J Royal Stat Soc, 162, 71-94.
  19. Sundquist M, Thorstenson S, Brudin L, Nordenskjöld B (1999). Applying the Nottingham prognostic index to a Swedish population. Breast Cancer Res Treat, 53, 1-8. https://doi.org/10.1023/A:1006052115874
  20. Todd JH, Dowle C, Williams MR, et al (1987). Confirmation of a Prognostic Index in primary breast cancer. Br J Cancer, 56, 489-92. https://doi.org/10.1038/bjc.1987.230
  21. Venkatesan P, Raman TT, Ponnuraja C(2011). Survival analysis of women with breast cancer under adjuvant therapy in South India. Asian Pac J Cancer Prev, 12,1533-5.
  22. Yu K, Lee CH, Tan PH, Hong GS, Wee SB, Wong CY, Tan P(2004). A molecular signature of the Nottingham Prognostic Index in breast cancer. Cancer Res, 64, 2962-68. https://doi.org/10.1158/0008-5472.CAN-03-2430

Cited by

  1. Predictive Factors for Supraclavicular Lymph Node Recurrence in N1 Breast Cancer Patients vol.14, pp.4, 2013, https://doi.org/10.7314/APJCP.2013.14.4.2509
  2. Breast Cancer Risk Factors in a Defined Population: Weighted Logistic Regression Approach for Rare Events vol.16, pp.2, 2013, https://doi.org/10.4048/jbc.2013.16.2.214
  3. Comparing Role of Two Chemotherapy Regimens, CMF and Anthracycline-Based, on Breast Cancer Survival in the Eastern Mediterranean Region and Asia by Multivariate Mixed Effects Models: a Meta-Analysis vol.16, pp.14, 2015, https://doi.org/10.7314/APJCP.2015.16.14.5655
  4. Survival Prognostic Factors of Male Breast Cancer in Southern Iran: a LASSO-Cox Regression Approach vol.16, pp.15, 2015, https://doi.org/10.7314/APJCP.2015.16.15.6773